| PE20.04 | The impact of TGF-β on the genital immune environment associated with HIV risk in young women | E-poster | Mucosal immunity |
| PE20.05 | Impact of gender affirmation surgery and exogenous hormones on mucosal immune responses and risk of HIV transmission in transgender women | E-poster | Mucosal immunity |
| PE20.06 | Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in women | E-poster | Mucosal immunity |
| PE20.07 | Effects of continued Progestin-based contraceptive usage in the adolescent genital tract: implications for HIV acquisition | E-poster | Mucosal immunity |
| PE20.08 | The impact of human immunodeficiency virus-1 viral replicative capacity on infection of human cervical and rectal tissue explants ex vivo | E-poster | Mucosal immunity |
| PU20.01 | Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participants | Publication Only | Mucosal immunity |
| PU20.02 | Asymptomatic bacterial STI in young men who have sex with men minimally alters rectal mucosal immune cell ecosystem | Publication Only | Mucosal immunity |
| OA05.03 | Compartment specific changes of Innate Lymphoid Cells within the intestinal mucosa of HIV-1 infected individuals | Oral Abstract Session | Microbiome & STI: impact on prevention |
| OA19.01 | Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trial | Oral Abstract Session | Microbiome & STI: impact on prevention |
| OA19.02 | Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new species | Oral Abstract Session | Microbiome & STI: impact on prevention |